Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-18

FDA Approved: BUTALBITAL, ASPIRIN, AND CAFFEINE — Original Application (LGM PHARMA SOLUTIONS, LLC)

View source ↗

Summary

FDA approved the original application for butalbital, aspirin, and caffeine (Butalbital, Aspirin, and Caffeine) submitted by LGM Pharma Solutions, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butalbital, Aspirin, and Caffeine (butalbital, aspirin, and caffeine)

Snippet

ORIG AP for BUTALBITAL, ASPIRIN, AND CAFFEINE (BUTALBITAL, ASPIRIN, AND CAFFEINE)